Teva Pharmaceutical Indus... (TEVA)
NYSE: TEVA
· Real-Time Price · USD
16.91
-0.59 (-3.37%)
At close: Jun 17, 2025, 3:59 PM
17.00
0.53%
After-hours: Jun 17, 2025, 04:50 PM EDT
-3.37% (1D)
| Bid | 16.9 |
| Market Cap | 19.39B |
| Revenue (ttm) | 16.61B |
| Net Income (ttm) | -1.28B |
| EPS (ttm) | -1.15 |
| PE Ratio (ttm) | -14.7 |
| Forward PE | 6.2 |
| Analyst | Buy |
| Ask | 17.17 |
| Volume | 11,666,509 |
| Avg. Volume (20D) | 12,091,247 |
| Open | 17.41 |
| Previous Close | 17.50 |
| Day's Range | 16.84 - 17.38 |
| 52-Week Range | 12.47 - 22.80 |
| Beta | 0.61 |
About TEVA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TEVA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TEVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
+4.42%
Teva Pharmaceutical Industries shares are trading ...
Unlock content with
Pro Subscription
1 month ago
+6.08%
Teva Pharmaceuticals shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $21 to $23.
